1. Home
  2. PPBT vs SPRC Comparison

PPBT vs SPRC Comparison

Compare PPBT & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

N/A

Current Price

$1.68

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$5.70

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPBT
SPRC
Founded
2010
2004
Country
Israel
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
2.5M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
PPBT
SPRC
Price
$1.68
$5.70
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
123.4K
1.2M
Earning Date
05-20-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.46
52 Week High
$5.18
$15.79

Technical Indicators

Market Signals
Indicator
PPBT
SPRC
Relative Strength Index (RSI) 29.07 40.82
Support Level $0.57 $3.02
Resistance Level $3.09 $6.30
Average True Range (ATR) 0.22 0.76
MACD 0.00 -0.48
Stochastic Oscillator 16.87 9.44

Price Performance

Historical Comparison
PPBT
SPRC

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: